Latest News
‘A Call to Action’: Dr. Peter Kuhn of USC Michelson Center Visits White House to Help Launch President Biden’s Cancer Moonshot Initiative
President Biden announced the relaunch of the Cancer Moonshot Initiative, which aims to reduce the cancer death rate in the United States by 50% over the next 25 years.
Eliminating the Uncertainty of Cancer Care is My Life’s Mission
Cancer is not an easy target, writes Dr. Peter Kuhn, founding director of the USC Michelson Convergent Science Institute in Cancer. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without lethality over the average lifespan.
New CSI-Cancer Lab Designed to Promote Collaboration
The USC Michelson Center for Convergent Bioscience has opened a new Convergent Science Institute in Cancer (CSI-Cancer) lab. Peter Kuhn, a founding member of the USC Michelson Center, made the announcement.
Epic Sciences and USC Michelson Center Partner to Improve Cancer Care
The USC Michelson Center for Convergent Bioscience and Epic Sciences, Inc. will work in concert to create more precise characterization of rare circulating tumor cells.
